The use of the activated clotting time for monitoring heparin therapy in critically ill patients
Jan J. De Waele(Ghent University Hospital), Francis Colardyn(European Society of Cardiology), Sebastiaan Van Cauwenberghe(Ghent University Hospital), Dominique Benoît(Ghent University Hospital), Eric A. J. Hoste(Ghent University Hospital)
Cited by 56
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units
|Critical Care Medicine|1998|3.5k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome
|Intensive Care Medicine|2013|1.6k
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k